Reduced Expression of Transcription Factor AP-2α Is Associated with Gastric Adenocarcinoma PrognosisReportar como inadecuado

Reduced Expression of Transcription Factor AP-2α Is Associated with Gastric Adenocarcinoma Prognosis - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.


This study aims to investigate the expression and prognostic significance of activator protein 2α AP-2α in gastric adenocarcinoma.

Methodology-Principal Findings

AP-2α expression was analyzed using real-time quantitative PCR RT-qPCR, western blotting, and immunohistochemical staining methods on tissue samples from a consecutive series of 481 gastric adenocarcinoma patients who underwent resections between 2003 and 2006. The relationship between AP-2α expression, clinicopathological factors, and patient survival was investigated. RT- qPCR results showed that the expression of AP-2α mRNA was reduced in tumor tissue samples, compared with expression in matched adjacent non-tumor tissue samples P = 0.009; this finding was confirmed by western blotting analysis P = 0.012. Immunohistochemical staining data indicated that AP-2α expression was significantly decreased in 196 of 481 40.7% gastric adenocarcinoma cases; reduced AP-2α expression was also observed in patients with poorly differentiated tumors P = 0.001 and total gastric carcinomas P = 0.002, as well as in patients who underwent palliative tumor resection P = 0.004. Additionally, reduced expression of AP-2α was more commonly observed in tumors that were staged as T4a-b P = 0.018, N3 P = 0.006, and M1 P = 0.008. Kaplan-Meier survival curves revealed that reduced expression of AP-2α was associated with poor prognosis in gastric adenocarcinoma patients P<0.001. Multivariate Cox analysis identified AP-2α expression as an independent prognostic factor for overall survival HR = 1.512, 95% CI = 1.127–2.029, P = 0.006.


Our data suggest that AP-2α plays an important role in tumor progression and that reduced AP-2α expression independently predicts an unfavorable prognosis in gastric adenocarcinoma patients.

Autor: Wei Wang , Lin Lv , Ke Pan, Yu Zhang, Jing-jing Zhao, Ju-gao Chen, Yi-bing Chen, Yong-qiang Li, Qi-jin Wang, Jia He, Shi-ping Che



Documentos relacionados